GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
How Is The Market Feeling About Viking Therapeutics?
Catalent Gains on Report It's Likely to Be Granted EU Approval for Novo Holdings Deal
Market Climbs, Bitcoin Close to $100k | Live Stock
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Viking Therapeutics a New Buy at B Riley on Lead Obesity Asset VK2735